BackgroundPoor pain control is common in perioperative orthopedic surgeries. However, there is a lack of exploration of the clinical pharmacy practice model for this population.
AimTo construct a perioperative pharmaceutical care model and clinical pathway for patients undergoing orthopedic surgeries and evaluate their impact on pain management.
MethodThis historical before-and-after study was conducted in the Department of Orthopedics of a tertiary hospital in Guangdong Province, China. The control group was surgical patients who received routine diagnosis and treatment. The intervention group received pain management from a multidisciplinary team based on a pharmacist-initiated pharmaceutical care practice model and clinical pathways for medication management. The primary outcome measures were postoperative pain at rest (PAR) and movement-evoked pain (MEP) scores, number of breakthrough pains, and length of hospital stay.
ResultsA total of 320 orthopedic surgery patients were included in the study. Among patients with expected moderate or severe postoperative pain (82.5%), signi cantly lower PAR and MEP scores were observed in the intervention group 24 hours after the operation compared to the control group (P<0.05). Compared to the control group, hospital stay in the intervention group was shortened by 2.3 days (P<0.001). However, there were no signi cant differences in the control of breakthrough pain and the incidence of adverse drug reactions (P>0.05).
ConclusionPharmacist-initiated multidisciplinary perioperative pain management practice models and clinical pathways could improve outcome indicators related to pain management and realize the role and value of pharmacists.